Clinical Trial Update: A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicating the completion of a study of HRS-1893 in healthy volunteers and patients with obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Obstructive Hypertrophic Cardiomyopathy | Phase 1 | Status: COMPLETED